Stock INLB ITEM 9 LABS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Item 9 Labs Corp. Share Price

Equities

INLB

US46564C2035

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 20:28:45 03/05/2024 BST 		5-day change 1st Jan Change
0.0002 USD 0.00% Intraday chart for Item 9 Labs Corp. +100.00% -89.47%
2023 Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
2023 Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023 CI

Financials

Sales 2021 21.94M 1.75B Sales 2022 21.76M 1.73B Capitalization 37.61M 3B
Net income 2021 -10M -797M Net income 2022 -31M -2.47B EV / Sales 2021 7.48 x
Net Debt 2021 19.48M 1.55B Net Debt 2022 27.76M 2.21B EV / Sales 2022 3 x
P/E ratio 2021
-11.5 x
P/E ratio 2022
-1.2 x
Employees 101
Yield 2021 *
-
Yield 2022
-
Free-Float 66.85%
More Fundamentals * Assessed data

Chart Item 9 Labs Corp.

Dynamic Chart

Latest news about Item 9 Labs Corp.

Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023 CI
Douglas Bowden Resign as Interim CEO of Item 9 Labs Corp CI
Item 9 Labs Corp. Announces Resignation of Shane Evans as A Member of the Board of Directors CI
Item 9 Labs Corp. cancelled the acquisition of Sessions Cannabis from Steven Fry, Najla Guthrie, Darryl Allen, Louis Laskovski, 2628146 Ontario Ltd. and 11949896 Canada Inc. CI
Item 9 Labs Corp. Announces Management Changes CI
Item 9 Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Item 9 Labs Corp. Announces Resignation of Michael Weinberger as Member of the Board of Directors CI
Item 9 Labs Corp. Announces CEO Changes CI
Item 9 Labs Corp. Announces the Resignation of Lawrence X. Taylor as Board of Director CI
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls CI
Item 9 Labs Corp. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
Item 9 Labs Corp. Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Item 9 Labs Corp. Auditor Raises 'Going Concern' Doubt CI
Item 9 Labs Corp. Announces Management Promotions CI
More news

Press releases Item 9 Labs Corp.

Item 9 Labs : Bankruptcy - Form 8-K PU
Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability BU
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Change in Directors or Principal Officers, Other Events (form 8-K) AQ
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls BU
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K) AQ
More press releases

Quotes and Performance

1 week+100.00%
1 month-33.33%
3 months-60.00%
6 months-96.55%
Current year-89.47%
More quotes

Highs and lows

1 week
0.00
Extreme 0.0001
0.00
1 month
0.00
Extreme 0.0001
0.00
Current year
0.00
Extreme 0.0001
0.00
1 year
0.00
Extreme 0.0001
0.10
3 years
0.00
Extreme 0.0001
3.90
5 years
0.00
Extreme 0
5.99
10 years
0.00
Extreme 0
8.40
More quotes

Managers and Directors - Item 9 Labs Corp.

Managers TitleAgeSince
Robert Mikkelsen DFI
 Director of Finance/CFO 43 14/10/18
Christopher Wolven COO
 Chief Operating Officer 41 31/12/18
Jeffrey Rassás BRD
 Director/Board Member 61 19/03/12
Members of the board TitleAgeSince
Jeffrey Rassás BRD
 Director/Board Member 61 19/03/12
Eric C. Kutscher BRD
 Director/Board Member 48 13/12/21
More insiders

Quotes

Date Price Change Volume
03/05/24 0.0002 0.00% 1,300
01/05/24 0.0002 0.00% 3,000,000
30/04/24 0.0002 +100.00% 3,000,025
29/04/24 0.0001 0.00% 200

Delayed Quote OTC Markets, May 03, 2024 at 08:28 pm

More quotes

Company Profile

Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. The Company offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vaporizer (vape) products, as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company operates through two segments: Cultivation and Franchising. Its product lines include Item 9 Labs Flower, Item 9 Labs Concentrates, and Orion 710.
Sector
Healthcare Facilities & Services
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

1st Jan change Capi.
ITEM 9 LABS CORP. Stock Item 9 Labs Corp.
-89.47% 140K
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+47.74% 275M
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+30.93% 274M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+48.84% 195M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-14.29% 145M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+57.96% 142M
THE CANNABIST COMPANY HOLDINGS INC. Stock The Cannabist Company Holdings Inc.
-31.21% 141M
INTERCURE LTD. Stock InterCure Ltd.
+147.89% 140M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
-7.69% 80.05M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
Medical Farming
  1. Stock Market
  2. Equities
  3. INLB Stock